Supplementary figures and figure legends
Figure S1 Rhein acts as an antagonist of liver X receptors (LXRs). 293T cells were transfected with a Gal4-responsive luciferase reporter and a series of chimeras in which the Gal4 DNA-binding domain was fused to the indicated nuclear hormone receptor ligand-binding domains (LBDs). Cells were treated with the appropriate agonist alone (white bars) or in combination with 12.5 μM rhein (black bars) for 24 h. Results are shown as the percent activities relative to the normalized luciferase activities in the presence of agonist alone (100%). The molecular targets and specific ligands used were as follows: peroxisome proliferator-activated receptor (PPAR) α, WY14643 (5 μM); PPARβ, GW0742 (1 μM); PPARγ, rosiglitazone (1 μM); retinoid X receptor (RXR), 9cis-retinoic acid (1 μM); pregnane X receptor (PXR), PCN (10 μM); farnesoid X receptor (FXR), chenodeoxycholic acid (10 μM); and LXR, GW3965 (1μM). 
